These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16641466)

  • 1. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.
    Gygax SE; Schuyler JA; Kimmel LE; Trama JP; Mordechai E; Adelson ME
    Antimicrob Agents Chemother; 2006 May; 50(5):1875-7. PubMed ID: 16641466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of erythromycin and clindamycin resistance genes in Group B Streptococcal clinical isolates and cervicovaginal-rectal swabs.
    Gygax SE; Schuyler JA; Trama JP; Mordechai E; Adelson ME
    Microb Drug Resist; 2007; 13(2):119-23. PubMed ID: 17650964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
    Pinheiro S; Radhouani H; Coelho C; Gonçalves A; Carvalho E; Carvalho JA; Ruiz-Larrea F; Torres C; Igrejas G; Poeta P
    Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.
    Desjardins M; Delgaty KL; Ramotar K; Seetaram C; Toye B
    J Clin Microbiol; 2004 Dec; 42(12):5620-3. PubMed ID: 15583291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms].
    Mollerach A; Méndez E; Massa R; Di Conza J
    Enferm Infecc Microbiol Clin; 2007 Jan; 25(1):67-8. PubMed ID: 17261249
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE; Wagner J; Arvand M
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
    Lo HH; Nien HH; Cheng YY; Su FY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):613-7. PubMed ID: 24856419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.
    Heelan JS; Hasenbein ME; McAdam AJ
    J Clin Microbiol; 2004 Mar; 42(3):1263-4. PubMed ID: 15004089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin-Susceptible but Clindamycin-Resistant Phenotype of Clinical ermB-PCR-Positive Group B Streptococci Isolates with IS1216E-Inserted ermB.
    Moroi H; Kimura K; Ido A; Banno H; Jin W; Wachino JI; Yamada K; Kikkawa F; Park YJ; Arakawa Y
    Jpn J Infect Dis; 2019 Nov; 72(6):420-422. PubMed ID: 31257242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and mechanisms of resistance of group B streptococcal isolates obtained at a community hospital.
    Varman M; Romero JR; Cornish NE; Manley J; Meza JL; Zach TL; Chartrand SA
    Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):431-3. PubMed ID: 15926062
    [No Abstract]   [Full Text] [Related]  

  • 11. Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates.
    Clifford V; Heffernan HM; Grimwood K; Garland S;
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):328-32. PubMed ID: 21806568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus.
    DiPersio LP; DiPersio JR
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):79-82. PubMed ID: 16368478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility.
    Dutra VG; Alves VM; Olendzki AN; Dias CA; de Bastos AF; Santos GO; de Amorin EL; Sousa MÂ; Santos R; Ribeiro PC; Fontes CF; Andrey M; Magalhães K; Araujo AA; Paffadore LF; Marconi C; Murta EF; Fernandes PC; Raddi MS; Marinho PS; Bornia RB; Palmeiro JK; Dalla-Costa LM; Pinto TC; Botelho AC; Teixeira LM; Fracalanzza SE
    BMC Infect Dis; 2014 Jun; 14():323. PubMed ID: 24919844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel keyhole phenotype in double-disk diffusion assays of clindamycin-resistant erythromycin-sensitive strains of Streptococcus agalactiae.
    Srinivasan U; Miller B; Debusscher J; Marrs CF; Zhang L; Seo YS; Oh KY; Kim MY; Yoon HR; Kl M; Foxman B
    Microb Drug Resist; 2011 Mar; 17(1):121-4. PubMed ID: 21166574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal spread of Streptococcus agalactiae resistant to clindamycin among pregnant women in Brazil.
    Barros RR; de Souza AF; Luiz FB
    J Antimicrob Chemother; 2016 Jul; 71(7):2054-6. PubMed ID: 27029847
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing molecular epidemiology of group B streptococcus in Korea.
    Seo YS; Srinivasan U; Oh KY; Shin JH; Chae JD; Kim MY; Yang JH; Yoon HR; Miller B; DeBusscher J; Foxman B; Ki M
    J Korean Med Sci; 2010 Jun; 25(6):817-23. PubMed ID: 20514299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa.
    Bolukaoto JY; Monyama CM; Chukwu MO; Lekala SM; Nchabeleng M; Maloba MR; Mavenyengwa RT; Lebelo SL; Monokoane ST; Tshepuwane C; Moyo SR
    BMC Res Notes; 2015 Aug; 8():364. PubMed ID: 26289147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany.
    Fluegge K; Supper S; Siedler A; Berner R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4444-6. PubMed ID: 15504878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.
    de Azavedo JC; McGavin M; Duncan C; Low DE; McGeer A
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3504-8. PubMed ID: 11709331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.